David M Ferguson (David Ferguson)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Cancers

ACS infectious diseases

Molecular pharmaceutics

ACS bio & med chem Au

University of Minnesota System

University of South Florida (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Minnesota System Sep 16 1991

United States

Professor :: Medicinal Chemistry

Education History

University of South Florida Sep 01 1983 - Jun 01 1989

United States

PHD :: Chemsitry

Bucknell University Sep 01 1979 - Jun 01 1983

United States

BSC :: Chemistry

Publications

Elly E Liao, Mu Yang, Noah Nathan Kochen, Nagamani Vunnam, Anthony R Braun, David M Ferguson, Jonathan N Sachs
Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite Pathology. Molecular neurobiology (2023)
Nagamani Vunnam, Mu Yang, Chih Hung Lo, Carolyn N Paulson, William D Fiers, Evan Huber, MaryJane Been, David M Ferguson, Jonathan N Sachs
Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling. ACS bio & med chem Au 3 (3) (2023)
Nagamani Vunnam, Mu Yang, Chih Hung Lo, Carolyn N Paulson, William D Fiers, Evan Huber, MaryJane Been, David M Ferguson, Jonathan N Sachs
Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling. ACS bio & med chem Au 3 (3) (2023)
Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S Griffith, David M Ferguson, Jayanth Panyam
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers 14 (24) (2022)
Diego E Escalante, Courtney C Aldrich, David M Ferguson
Parameterization and Application of the General Amber Force Field to Model Fluoro Substituted Furanose Moieties and Nucleosides. Molecules (Basel, Switzerland) 27 (9) (2022)
Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S Griffith, David M Ferguson, Jayanth Panyam
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers 14 (24) (2022)
Hyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, Wenqiu Zhang, Drishti Sehgal, David M Ferguson, Thomas S Griffith, Jayanth Panyam
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy. Molecular pharmaceutics 17 (6) (2020)
Xu Wang, Yuna Zeng, Li Sheng, Peter Larson, Xue Liu, Xiaowen Zou, Shufang Wang, Kaijing Guo, Chen Ma, Gang Zhang, Huaqing Cui, David M Ferguson, Yan Li, Jingren Zhang, Courtney C Aldrich
A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniae. Journal of medicinal chemistry 62 (5) (2019)
Hyunjoon Kim, Vidhi Khanna, Tamara A Kucaba, Wenqiu Zhang, David M Ferguson, Thomas S Griffith, Jayanth Panyam
Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine. Molecular pharmaceutics 16 (3) (2019)
Matthew R Bockman, Curtis A Engelhart, Julia D Cramer, Michael D Howe, Neeraj K Mishra, Matthew Zimmerman, Peter Larson, Nadine Alvarez-Cabrera, Sae Woong Park, Helena I M Boshoff, James M Bean, Victor G Young, David M Ferguson, Veronique Dartois, Joseph T Jarrett, Dirk Schnappinger, Courtney C Aldrich
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin Synthase. ACS infectious diseases 5 (4) (2019)
Matthew R Bockman, Curtis A Engelhart, Surendra Dawadi, Peter Larson, Divya Tiwari, David M Ferguson, Dirk Schnappinger, Courtney C Aldrich
Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside Modification. ACS infectious diseases 4 (7) (2018)

David M Ferguson.css-eqlu8i{font-size:small;padding-left:4px;} (David Ferguson)

Publication Activity (10 Years)

Top Topics

Top Venues

David M Ferguson (David Ferguson)